Back to Portfolio

BioTech

TRASE srl

TRASE's mission is to validate a marker of cerebral oxidative stress (European patent EP 2961848) that reflects neurodegenerative conditions, and Alzheimer's disease in particular, including in the early, pre-clinical stages. The marker is also a therapeutic target. TRASE addresses the pharmaceutical industry and the clinical diagnostics market.

BioTechDiagnostics
CROWDFUNDING SOON
TRASE srl

MORE STARTUPS IN BioTech

UPCOMING LAUNCH

FUNDRAISING COMING SOON

We are preparing the launch of a crowdfunding campaign to support the growth of TRASE srl. Sign up to receive all the details in preview.

KEEP ME POSTED

WANT TO KNOW MORE?

Contact us for more information about our startups or to submit your project.

CONTACT US